Selected research
Industry Research
Atorvastatin Industry Research Report 2026
Market perspective
The global Atorvastatin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Atorvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Atorvastatin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Atorvastatin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Atorvastatin include Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, Pfizer, Morepen, DSM Sinochem Pharmaceuticals, Combi-Blocks, Cadila Pharmaceuticals and Apotex Pharmachem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Atorvastatin market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atorvastatin Market by Company
Teva Pharmaceutical Industries
Sun Pharmaceutical Industries
Pfizer
Morepen
DSM Sinochem Pharmaceuticals
Combi-Blocks
Cadila Pharmaceuticals
Apotex Pharmachem
Atorvastatin Segment by Type
Chemical Synthesis
Biocatalysis
Atorvastatin Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Atorvastatin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atorvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atorvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atorvastatin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atorvastatin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atorvastatin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atorvastatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Synthesis
- Biocatalysis
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Teva Pharmaceutical Industries
- Sun Pharmaceutical Industries
- Pfizer
- Morepen
- DSM Sinochem Pharmaceuticals
- Combi-Blocks
- Cadila Pharmaceuticals
- Apotex Pharmachem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atorvastatin Market Size (2021-2032)
- 2.2.2 Global Atorvastatin Sales (2021-2032)
- 2.2.3 Global Atorvastatin Market Average Price (2021-2032)
- 2.3 Atorvastatin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Synthesis
- 2.3.3 Biocatalysis
- 2.4 Atorvastatin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atorvastatin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atorvastatin Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Atorvastatin Revenue of Manufacturers (2021-2026)
- 3.4 Global Atorvastatin Average Price by Manufacturers (2021-2026)
- 3.5 Global Atorvastatin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atorvastatin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atorvastatin, Product Type & Application
- 3.8 Global Manufacturers of Atorvastatin, Established Date
- 3.9 Global Atorvastatin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical Industries
- 4.1.1 Teva Pharmaceutical Industries Company Information
- 4.1.2 Teva Pharmaceutical Industries Business Overview
- 4.1.3 Teva Pharmaceutical Industries Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Industries Atorvastatin Product Portfolio
- 4.1.5 Teva Pharmaceutical Industries Recent Developments
- 4.2 Sun Pharmaceutical Industries
- 4.2.1 Sun Pharmaceutical Industries Company Information
- 4.2.2 Sun Pharmaceutical Industries Business Overview
- 4.2.3 Sun Pharmaceutical Industries Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Industries Atorvastatin Product Portfolio
- 4.2.5 Sun Pharmaceutical Industries Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Atorvastatin Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Morepen
- 4.4.1 Morepen Company Information
- 4.4.2 Morepen Business Overview
- 4.4.3 Morepen Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Morepen Atorvastatin Product Portfolio
- 4.4.5 Morepen Recent Developments
- 4.5 DSM Sinochem Pharmaceuticals
- 4.5.1 DSM Sinochem Pharmaceuticals Company Information
- 4.5.2 DSM Sinochem Pharmaceuticals Business Overview
- 4.5.3 DSM Sinochem Pharmaceuticals Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DSM Sinochem Pharmaceuticals Atorvastatin Product Portfolio
- 4.5.5 DSM Sinochem Pharmaceuticals Recent Developments
- 4.6 Combi-Blocks
- 4.6.1 Combi-Blocks Company Information
- 4.6.2 Combi-Blocks Business Overview
- 4.6.3 Combi-Blocks Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Combi-Blocks Atorvastatin Product Portfolio
- 4.6.5 Combi-Blocks Recent Developments
- 4.7 Cadila Pharmaceuticals
- 4.7.1 Cadila Pharmaceuticals Company Information
- 4.7.2 Cadila Pharmaceuticals Business Overview
- 4.7.3 Cadila Pharmaceuticals Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cadila Pharmaceuticals Atorvastatin Product Portfolio
- 4.7.5 Cadila Pharmaceuticals Recent Developments
- 4.8 Apotex Pharmachem
- 4.8.1 Apotex Pharmachem Company Information
- 4.8.2 Apotex Pharmachem Business Overview
- 4.8.3 Apotex Pharmachem Atorvastatin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Apotex Pharmachem Atorvastatin Product Portfolio
- 4.8.5 Apotex Pharmachem Recent Developments
5 Global Atorvastatin Market Scenario by Region
- 5.1 Global Atorvastatin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atorvastatin Sales by Region: 2021-2032
- 5.2.1 Global Atorvastatin Sales by Region: 2021-2026
- 5.2.2 Global Atorvastatin Sales by Region: 2027-2032
- 5.3 Global Atorvastatin Revenue by Region: 2021-2032
- 5.3.1 Global Atorvastatin Revenue by Region: 2021-2026
- 5.3.2 Global Atorvastatin Revenue by Region: 2027-2032
- 5.4 North America Atorvastatin Market Facts & Figures by Country
- 5.4.1 North America Atorvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atorvastatin Sales by Country (2021-2032)
- 5.4.3 North America Atorvastatin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atorvastatin Market Facts & Figures by Country
- 5.5.1 Europe Atorvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atorvastatin Sales by Country (2021-2032)
- 5.5.3 Europe Atorvastatin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atorvastatin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atorvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atorvastatin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atorvastatin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atorvastatin Market Facts & Figures by Country
- 5.7.1 South America Atorvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atorvastatin Sales by Country (2021-2032)
- 5.7.3 South America Atorvastatin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Atorvastatin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atorvastatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atorvastatin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atorvastatin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atorvastatin Sales by Type (2021-2032)
- 6.1.1 Global Atorvastatin Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Atorvastatin Sales Market Share by Type (2021-2032)
- 6.2 Global Atorvastatin Revenue by Type (2021-2032)
- 6.2.1 Global Atorvastatin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atorvastatin Revenue Market Share by Type (2021-2032)
- 6.3 Global Atorvastatin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atorvastatin Sales by Application (2021-2032)
- 7.1.1 Global Atorvastatin Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Atorvastatin Sales Market Share by Application (2021-2032)
- 7.2 Global Atorvastatin Revenue by Application (2021-2032)
- 7.2.1 Global Atorvastatin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atorvastatin Revenue Market Share by Application (2021-2032)
- 7.3 Global Atorvastatin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atorvastatin Value Chain Analysis
- 8.1.1 Atorvastatin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atorvastatin Production Mode & Process
- 8.2 Atorvastatin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atorvastatin Distributors
- 8.2.3 Atorvastatin Customers
9 Global Atorvastatin Analyzing Market Dynamics
- 9.1 Atorvastatin Industry Trends
- 9.2 Atorvastatin Industry Drivers
- 9.3 Atorvastatin Industry Opportunities and Challenges
- 9.4 Atorvastatin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst